Site of relapse of ductal adenocarcinoma of the pancreas affects survival after multimodal therapy

Ductal adenocarcinoma of the pancreas (PDAC) remains one of the most lethal malignancies. To date, no guidelines exists for isolated resectable metachronous disease. It is still unknown, which patients may ben...

Source: BMC Surgery - March 3, 2021 Category: Surgery Authors: S. A. Safi, N. Lehwald-Tywuschik, A. Rehders, G. Fluegen, L. Haeberle, V. Keitel and W. T. Knoefel Tags: Research article Source Type: research